共 41 条
- [1] UNGARO R, MEHANDRU S, ALLEN P B, Et al., Ulcerative colitis, Lancet, 389, pp. 1756-1770, (2017)
- [2] BAUMGART D C, CARDING S R., Inflammatory bowel disease: cause and immunobiology, Lancet, 369, pp. 1627-1640, (2007)
- [3] MOLODECKY N A, SOON I S, RABI D M, Et al., Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 1, pp. 46-54, (2012)
- [4] HOU J K, EL-SERAG H, THIRUMURTHI S., Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review, The American Journal of Gastroenterology, 104, 8, pp. 2100-2109, (2009)
- [5] JAIRATH V, FEAGAN B G., Global burden of inflammatory bowel disease, Lancet Gastroenterology & Hepatology, 5, 1, pp. 2-3, (2020)
- [6] HUANG Y, YANG Q, MI X, Et al., Ripened Pu-erh tea extract promotes gut microbiota resilience against dextran sulfate sodium induced colitis, Journal of Agricultural and Food Chemistry, 69, 7, pp. 2190-2203, (2021)
- [7] WIRTZ S, POPP V, KINDERMANN M, Et al., Chemically induced mouse models of acute and chronic intestinal inflammation, Nature Protocols, 12, 7, pp. 1295-1309, (2017)
- [8] LIU S, ZHAO W, LAN P, Et al., The microbiome in inflammatory bowel diseases: from pathogenesis to therapy, Protein & Cell, 12, 5, pp. 331-345, (2020)
- [9] GEVERS D, KUGATHASAN S, DENSON L A, Et al., The treatment-naive microbiome in new-onset Crohn’s disease, Cell Host & Microbe, 15, 3, pp. 382-392, (2014)
- [10] LLOYD-PRICE J, ARZE C, ANANTHAKRISHNAN A N, Et al., Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases, Nature, 569, pp. 655-662, (2019)